All Pathways
Hepatobiliary SurgeryEmergency

Acute Cholangitis - Hepatobiliary Surgery Pathway (TG18)

Acute Cholangitis - Hepatobiliary Surgery Pathway (TG18): Acute Cholangitis - Hepatobiliary Referral → Hepatobiliary Assessment → TG18 Severity Grading ...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Acute Cholangitis - Hepatobiliary Referral

    Complex/refractory cases or ERCP failure

    1. Action

      Hepatobiliary Assessment

      When is HPB consultation needed?

      • INDICATIONS FOR HPB CONSULT:
      • - Failed ERCP (2+ attempts)
      • - Complex biliary anatomy
      • - Surgical etiology (bile duct injury)
      • - Malignant biliary obstruction
      • - Grade III (severe) cholangitis
      • - Recurrent cholangitis
      1. Decision

        TG18 Severity Grading

        Determines urgency

        • Grade I: Mild - No organ dysfunction
        • Grade II: Moderate - Risk factors
        • Grade III: Severe - Organ dysfunction
        1. Warning

          Grade III (Severe)

          URGENT biliary drainage

          • ANY ONE organ dysfunction:
          • - Hypotension requiring pressors
          • - Altered mental status
          • - PaO2/FiO2 <300
          • - Creatinine >2.0 mg/dL
          • - INR >1.5
          • - Platelets <100,000
          • REQUIRES:
          • - ICU admission
          • - Urgent drainage (<12-24h)
          • - Organ support
          1. Action

            Biliary Drainage Hierarchy

            HPB surgeon coordinates approach

            • 1. ERCP (if not failed/contraindicated)
            • - Success rate 90-95%
            • 2. PTC (percutaneous transhepatic)
            • - When ERCP fails
            • - Proximal obstruction
            • - Altered anatomy (Roux-en-Y)
            • 3. EUS-guided drainage (emerging)
            • 4. SURGICAL drainage (last resort)
            1. Action

              PTC Drainage

              When ERCP not possible

              • Percutaneous transhepatic cholangiography
              • INDICATIONS:
              • - Failed ERCP
              • - Roux-en-Y anatomy
              • - Proximal obstruction (Klatskin)
              • - Duodenal obstruction
              • TECHNIQUE:
              • - US or fluoro-guided
              • - Right > left approach usually
              • - External drain initially
              • - Can convert to internal later
              1. Action

                Definitive Source Management

                After stabilization

                • CHOLEDOCHOLITHIASIS:
                • - CBD clearance (ERCP/surgery)
                • - Cholecystectomy (interval or same admission)
                • MALIGNANT STRICTURE:
                • - Staging workup
                • - Metal stent vs surgery
                • - Oncology consultation
                • BILE DUCT INJURY:
                • - Hepaticojejunostomy (delayed)
                • - Referral to high-volume center
                • BENIGN STRICTURE:
                • - Serial dilation/stenting
                • - Consider surgical bypass
                1. Action

                  Antibiotic Management

                  Empiric coverage

                  • EMPIRIC (before cultures):
                  • - Pip-Tazo 4.5g IV q6h OR
                  • - Ceftriaxone + Metronidazole OR
                  • - Meropenem (if MDR risk)
                  • ADJUST per culture results
                  • DURATION:
                  • - 4-7 days after source control
                  • - Longer if undrained/bacteremia
                  1. Action

                    Post-Drainage Surveillance

                    Monitor for complications

                    • Serial LFTs (daily until improving)
                    • Repeat imaging if not improving
                    • Drain output monitoring
                    • Watch for: Recurrent cholangitis, abscess, leak
                    • Plan for definitive surgery if needed
                    1. Outcome

                      Outcomes

                      Prognosis

                      • Grade I: Mortality <1%
                      • Grade II: Mortality 5-10%
                      • Grade III: Mortality 10-30%
                      • Delay in drainage: Increased mortality
                      • Surgical drainage: Higher morbidity but effective
              2. Warning

                Surgical Biliary Drainage

                When interventional approaches fail

                • INDICATIONS:
                • - Failed ERCP + PTC
                • - Peritonitis requiring laparotomy
                • - Bile duct injury requiring repair
                • - Gallbladder source (cholecystectomy)
                • OPTIONS:
                • - CBD exploration + T-tube
                • - Cholecystostomy (if high-risk)
                • - Choledochojejunostomy (rare acute)
                • HIGH MORBIDITY in acute setting

Guideline Source

Tokyo Guidelines 2018 (TG18) - Surgical Management of Cholangitis

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Severity may evolve rapidly
  • ERCP availability varies
  • Surgical drainage reserved for failed endoscopic/percutaneous
  • Elderly/immunocompromised may not mount typical response

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Acute Cholangitis - Hepatobiliary Surgery Pathway (TG18)?

The Acute Cholangitis - Hepatobiliary Surgery Pathway (TG18) is a emergency clinical algorithm for Hepatobiliary Surgery. It provides a structured decision tree to guide clinical decision-making, based on Tokyo Guidelines 2018 (TG18) - Surgical Management of Cholangitis.

What guideline is the Acute Cholangitis - Hepatobiliary Surgery Pathway (TG18) based on?

This algorithm is based on Tokyo Guidelines 2018 (TG18) - Surgical Management of Cholangitis (DOI: 10.1002/jhbp.518).

What are the limitations of the Acute Cholangitis - Hepatobiliary Surgery Pathway (TG18)?

Known limitations include: Severity may evolve rapidly; ERCP availability varies; Surgical drainage reserved for failed endoscopic/percutaneous; Elderly/immunocompromised may not mount typical response. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Acute Cholangitis - Hepatobiliary Surgery Pathway (TG18) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free